Takashi Shigematsu

6PUBLICATIONS
10CO-AUTHORS
Toxicology (incl. clinical toxicology)Pharmaceutical delivery technologiesPsychosocial aspects of childbirth and perinatal mental healthTraditional Chinese medicine and treatmentsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 11, 2023
Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism: A Randomized Placebo-Controlled Trial.

Takashi Shigematsu, Fumihiko Koiwa, Yoshitaka Isaka

|Feb 17, 2022
Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism.

Takashi Shigematsu, Shinji Asada, Yuichi Endo

|Jun 05, 2020
Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis.

Takashi Shigematsu, Shinji Asada, Yuichi Endo

|Jun 01, 2020
Comparison of bioelectrical impedance analysis in healthy pregnant women and patient on hemodialysis.

Seiji Hashimoto, Tomochika Maoka, Rie Yamamoto

|Nov 26, 2019
Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism.

Takashi Shigematsu, Masafumi Fukagawa, Keitaro Yokoyama

|Feb 17, 2017
Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials.

Takashi Shigematsu, Ryoichi Muraoka, Toshitsugu Sugimoto

Pageof 1

Frequent Collaborators

2 joint publications

Shinji Asada

2 joint publications

Masafumi Fukagawa

2 joint publications

Tadao Akizawa

1 joint publications

Seiji Hashimoto